View from the top: expert opinion from leading specialists
The approach to managing anaemia of CKD is changing rapidly, thanks in part to the introduction of a new treatment category, HIF-PH inhibitors. Here we share opinion from experts in the field.
Professor Mishio Xao on the challenges of managing anaemia of CKD
Professor Mishio Xao on the challenges of managing anaemia of CKD
CKD, chronic kidney disease; HIF-PH, hypoxia-inducible factor prolyl-hydroxylase.
Reporting Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to SKF Pharma Ltd. on 0800 783 5018